Capstone Triton Financial Group, LLC Gsk PLC Transaction History

Capstone Triton Financial Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $1.26 Million - $1.43 Million	-29,877 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$40.23 - $47.74 $8,810 - $10,455	219 Added 0.74%	29,877 $1.36 Million
Q4 2021 Feb 11, 2022	SELL	$38.88 - $45.31 $3,693 - $4,304	-95 Reduced 0.32%	29,658 $1.31 Million
Q3 2021 Nov 12, 2021	SELL	$38.79 - $43.16 $61,637 - $68,581	-1,589 Reduced 5.07%	29,753 $1.18 Million
Q2 2021 Aug 09, 2021	SELL	$36.52 - $41.46 $105,834 - $120,151	-2,898 Reduced 8.46%	31,342 $1.25 Million

Q1 2021 May 17, 2021	SELL	$34.27 - $40.01 $156,716 - $182,965	-4,573 Reduced 11.78%	34,240 $1.22 Million
Q4 2020 Jan 28, 2021	BUY	$34.07 - $39.94 $1.32 Million - $1.55 Million	38,813 New	38,813 $1.43 Million

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $77.7B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Capstone Triton Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Triton Financial Group, LLC with notifications on news.